Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 05 January 2026

Sec. NK and Innate Lymphoid Cell Biology

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1773500

Correction: Genetic polymorphisms in cGAS-STING-mediated type I interferon innate immune signaling pathway are associated with DLBCL

Qirui Zhou&#x;Qirui Zhou1†Ruinan Jia&#x;Ruinan Jia1†Jinlin ChenJinlin Chen1Yang TanYang Tan1Yuechan MaYuechan Ma1Mengfan LuanMengfan Luan1Xue ShengXue Sheng1Xiao HanXiao Han1Shuying LiShuying Li1Fei Lu,Fei Lu1,2Chunyan Ji,*Chunyan Ji1,2*Dongmei Wang,*Dongmei Wang1,2*Jingjing Ye,*Jingjing Ye1,2*
  • 1Department of Hematology, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, China
  • 2Shandong Key Laboratory of Hematological Diseases and Immune Microenvironment, Qilu Hospital of Shandong University, Shandong University, Jinan, China

A Correction on
Genetic polymorphisms in cGAS-STING-mediated type I interferon innate immune signaling pathway are associated with DLBCL

By Zhou Q, Jia R, Chen J, Tan Y, Ma Y, Luan M, Sheng X, Han X, Li S, Lu F, Ji C, Wang D and Ye J (2025) Front. Immunol. 16:1725218. doi: 10.3389/fimmu.2025.1725218

Affiliation “Department of Hematology, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, China” was omitted for author Dongmei Wang. This affiliation has now been added for author Dongmei Wang.

Affiliation “Shandong Key Laboratory of Hematological Diseases and Immune Microenvironment, Qilu Hospital of Shandong University, Shandong University, Jinan, China” was omitted for author Fei Lu. This affiliation has now been added for author Fei Lu.

The original version of this article has been updated.

Keywords: DLBCL, innate immune, prognosis, SNPs, treatment response

Citation: Zhou Q, Jia R, Chen J, Tan Y, Ma Y, Luan M, Sheng X, Han X, Li S, Lu F, Ji C, Wang D and Ye J (2026) Correction: Genetic polymorphisms in cGAS-STING-mediated type I interferon innate immune signaling pathway are associated with DLBCL. Front. Immunol. 16:1773500. doi: 10.3389/fimmu.2025.1773500

Received: 22 December 2025; Accepted: 23 December 2025; Revised: 22 December 2025;
Published: 05 January 2026.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2026 Zhou, Jia, Chen, Tan, Ma, Luan, Sheng, Han, Li, Lu, Ji, Wang and Ye. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Chunyan Ji, amljaHVueWFuQHNkdS5lZHUuY24=; Dongmei Wang, ZG9uZ21laXdhbmdAc2R1LmVkdS5jbg==; Jingjing Ye, eWVqaW5namluZ0BzZHUuZWR1LmNu

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.